WT-1 is required for early kidney development

In humans, germline mutations of the WT-1 tumor suppressor gene are associated with both Wilms' tumors and urogenital malformations. To develop a model system for the molecular analysis of urogenital development, we introduced a mutation into the murine WT-1 tumor suppressor gene by gene targeting in embryonic stem cells. The mutation resulted in embryonic lethality in homozygotes, and examination of mutant embryos revealed a failure of kidney and gonad development. Specifically, at day 11 of gestation, the cells of the metanephric blastema underwent apoptosis, the ureteric bud failed to grow out from the Wolffian duct, and the inductive events that lead to formation of the metanephric kidney did not occur. In addition, the mutation caused abnormal development of the mesothelium, heart, and lungs. Our results establish a crucial role for WT-1 in early urogenital development.

[1]  L. Sorokin,et al.  Development and growth of mouse embryonic kidney in organ culture and modulation of development by soluble growth factor. , 1991, Developmental biology.

[2]  D. Housman,et al.  A tumor chromosome rearrangement further defines the 11p13 Wilms tumor locus. , 1991, Genomics.

[3]  D. Housman,et al.  A mouse model of the aniridia-Wilms tumor deletion syndrome. , 1990, Science.

[4]  J. Wilkinson,et al.  Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities , 1993, Nature.

[5]  D. Housman,et al.  Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome , 1991, Cell.

[6]  M. Rudnicki,et al.  Inactivation of MyoD in mice leads to up-regulation of the myogenic HLH gene Myf-5 and results in apparently normal muscle development , 1992, Cell.

[7]  D. Housman,et al.  WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour , 1991, Nature.

[8]  Z. Wang,et al.  The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene. , 1992, The Journal of biological chemistry.

[9]  Rudolf Jaenisch,et al.  Targeted mutation of the DNA methyltransferase gene results in embryonic lethality , 1992, Cell.

[10]  L. Saxén,et al.  Embryonic kidney in organ culture. , 1987, Differentiation; research in biological diversity.

[11]  G I Bell,et al.  Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1. , 1992, Science.

[12]  C. Grobstein.  Inductive interaction in the development of the mouse metanephros , 1955 .

[13]  J. Bard,et al.  The candidate Wilms' tumour gene is involved in genitourinary development , 1990, Nature.

[14]  M. Capecchi,et al.  Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells , 1987, Cell.

[15]  G. Dressler,et al.  Pax-2 is a DNA-binding protein expressed in embryonic kidney and Wilms tumor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[16]  D. Housman,et al.  Smallest region of overlap in Wilms tumor deletions uniquely implicates an 11p13 zinc finger gene as the disease locus. , 1991, Genomics.

[17]  A. Berns,et al.  Requirement for a functional Rb-1 gene in murine development , 1992, Nature.

[18]  C. Junien,et al.  Role for the Wilms tumor gene in genital development? , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[19]  D. Housman,et al.  An internal deletion within an 11p13 zinc finger gene contributes to the development of Wilms' tumor , 1990, Cell.

[20]  D. Housman,et al.  Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus , 1990, Cell.

[21]  D. Housman,et al.  Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome. , 1992, Oncogene.

[22]  M. Rudnicki,et al.  Simplified mammalian DNA isolation procedure. , 1991, Nucleic acids research.

[23]  R. Erickson.  Inductive interactions in the development of the mouse metanephros. , 1968 .

[24]  P. Smith,et al.  Zinc finger point mutations within the WT1 gene in Wilms tumor patients. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[25]  D. Housman,et al.  Expression of the Wilms' tumor gene WT1 in the murine urogenital system. , 1991, Genes & development.

[26]  L. Saxén.  Organogenesis of the kidney , 1987 .

[27]  P. Gruss,et al.  Pax2, a new murine paired-box-containing gene and its expression in the developing excretory system. , 1990, Development.

[28]  D. Housman,et al.  Alternative splicing and genomic structure of the Wilms tumor gene WT1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[29]  R. Weinberg,et al.  Effects of an Rb mutation in the mouse , 1992, Nature.

[30]  Q. Al-Awqati,et al.  Apoptosis in metanephric development , 1992, The Journal of cell biology.

[31]  D. Housman,et al.  The genetics of Wilms' tumor. , 1992, Advances in cancer research.

[32]  A. Knudson,et al.  Mutation and cancer: a model for Wilms' tumor of the kidney. , 1972, Journal of the National Cancer Institute.

[33]  R Kemler,et al.  The in vitro development of blastocyst-derived embryonic stem cell lines: formation of visceral yolk sac, blood islands and myocardium. , 1985, Journal of embryology and experimental morphology.

[34]  D. Housman,et al.  Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development , 1991, Molecular and cellular biology.

[35]  A. Bradley,et al.  Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis , 1992, Nature.

[36]  C. Grobstein.  Inductive epitheliomesenchymal interaction in cultured organ rudiments of the mouse. , 1953, Science.

[37]  A. Bradley.  Production and analysis of chimeric mice , 1987 .

[38]  D. Housman,et al.  Structural rearrangements of the WT1 gene in Wilms' tumour cells. , 1991, Oncogene.

[39]  V. Sukhatme,et al.  Characterization of the zinc finger protein encoded by the WT1 Wilms' tumor locus. , 1991, Oncogene.

[40]  D. J. Driscoll,et al.  A highly polymorphic locus cloned from the breakpoint of a chromosome 11p13 deletion associated with the WAGR syndrome. , 1989, Genomics.

[41]  L. Saxén,et al.  Are morphogenetic tissue interactions mediated by transmissible signal substances or through cell contacts? , 1976, Nature.

[42]  D. Housman,et al.  Evidence for WT1 as a Wilms tumor (WT) gene: intragenic germinal deletion in bilateral WT. , 1991, American journal of human genetics.

[43]  W. Bickmore,et al.  Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript. , 1992, Science.

[44]  V. Sukhatme.  The Egr transcription factor family: from signal transduction to kidney differentiation. , 1992, Kidney international.

[45]  D. Housman,et al.  Germline intronic and exonic mutations in the Wilms' tumour gene (WT1) affecting urogenital development , 1992, Nature Genetics.

[46]  A. Poustka,et al.  Homozygous deletion in Wilms tumours of a zinc-finger gene identified by chromosome jumping , 1990, Nature.

[47]  Peter Gruss,et al.  Pax in development , 1992, Cell.

[48]  T. Curran,et al.  Binding of the Wilms' tumor locus zinc finger protein to the EGR-1 consensus sequence. , 1990, Science.

[49]  J. Bard,et al.  The expression of the Wilms' tumour gene, WT1, in the developing mammalian embryo , 1993, Mechanisms of Development.